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Over the past few years, the NMDA receptor has undoubtedly 
been the focus of more attention than any other excitatory 
amino acid receptor. The book is the result of a symposium 
held at Bristol University in April, 1989. The organisers’ 
stated intention was to focus on the NMDA receptor and by 
bringing together international experts to provide both an 
introduction to the field and an overview of current research. 
To one on the periphery of NMDA research, the meeting 
certainIy achieved these goaIs and that success is reflected in 
the book. 
There are seventeen chapters in all ranging from medicinal 
chemistry to behaviour. One is left with a general impression 
that many of the rapid advances in NMDA research are the 
result of an early and continuing involvement of the chemists. 
This has provided the pharmac~p~ia needed to characterise 
and explore the receptor system. Nowhere is this more evident 
than in the first three chapters on the history of the NMDA 
receptor concept, and on competitive agonists and 
antagonists and non-competitive antagonists. Autoradio- 
graphy of the NMDA receptors emphasises the cerebral 
regional variability and provides evidence for agonist- vs 
antagonist-preferring receptor subtypes. El~rophys~ologi~ 
studies focus on the role of NMDA receptors in synaptic 
pathways and in neural network organization. investigations 
of the NMDA Ca*+ channel and the role of Mg’” as well as 
the glycine modulation of receptor events provide important 
information related to chapters on neuronal plasticity (long- 
term potentiatio~ in the hippocampus and developmental 
plasticity in the visual cortex), learning and memory and 
epilepsy. All this background then leads to a discussion of the 
clinical imphcations for NMDA receptor drugs and their roIes 
in anticonvulsive therapy, nenroprot~tion, psychiatric 
disorders, hormonal disturbances and other neurologic indi- 
cations. This is further expanded in individual chapters on 
neuronal development and degradation and on competitive 
antagonists (epilepsy, spasticity and neuroprotectian) as 
drugs and on non-~mpetitive antagonists (neuroprote~ion~ 
as drugs. Fir&y, the editors provide an overview and 
references to aspects of NMDA research which could not be 
covered at the meeting. This includes physiological aspects as 
pain, stress, thermoregulation, respiration, ingestive be- 
haviour, alcohol and sleep. 
There is no doubt that this text provides a very thorough 
and ~mprehensive introdu~t~o~overview to NMDA 
excitatory amino acid research. Much of the work presented 
is already in the literature, but this book brings it together 
into a single source for the first time. My only criticism of the 
contributions is the lack of much speculation as to future 
directions for research, for example about the glycine 
moduIatory site and its potential clinical impfications. 
Finally, the book is extremely weli produced and easy to read. 
It must become an essential addition to any library, but at f25 
in paperback, it is also affordable for any one interested in 
this field. 
R. Bruce Holman 
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One can readily endorse the publisher’s description of this 
book as a ‘thorough and expert overview of progress in this 
field’. Virtually all metabolites of arachidonic acid - the 
number of which continues to multiply - receive due 
mention. Fluctuations in their concentrations, by both 
synthesis and degradatjon, in normal and ~~ea~/injured 
tissues, the possible causes and consequences of such 
fluctuations, the mechanisms by which they exert thelr effects 
and developments of drugs to counteract these effects are 
reported for most systems of the body. This is to be expected 
in the published proceedings of the week-long Second 
Internationaf Conference on Leukotrienes and Prostanoids in 
Health and Disease (LPI-ID) which took place in JerusaIem in 
October 1988. The editors are to be congratulated on its 
relativeIy rapid publication in a very readable format which 
groups brief review articles with commendably short papers 
presenting new experimental results. Seven papers deal with 
molecular biological aspects of cycle-oxygenase and 
lipoxygenase. These are f&lowed by sections on new drugs 
(10 papers), allergy, asthma, immunology and i~~ammat~on 
(11 papers), brain (5 papers), anaphylaxis and shock (8 
papers), cardiovasculature (5 papers), localisation of PLAz (5 
papers), reproductive biology and the endocrine system (5 
papers) and cancer (3 papers). The fina paper reviews the 
biological activities of lipoxins. AI1 of the papers are well 
referenced. There are, as would be expected, considerable 
interrelationships between papers in the different sections, 
appreciation of which is aided by helpfut indexing of the 
volume. However, whereas the roles of arachidonate 
metabolites in contributing to tissue injury on the one hand 
and in cytoprotection on the other hand are dealt with in 
virtually all sections, this is not adequately reflected in the 
index. Also, while most papers follow the norm in using only 
acceptable abbreviations defined on first mention, 
prostaglandin endoperoxide synthase is abbreviated to COX 
in one paper and to PES in another paper. And the use of Et 
for estradiol may be confusing in the context of 
prostaglandins! 
There is much information of interest to scientists af all 
biological and medical disciplines in this book. It will be of 
particular interest to researchers in this exciting field, who, 
however, may find the cost prohibitive. 
MichaeI Ci. Harrington 
